Treprostinil is a stable from of synthetic prostacyclin with a half-life of several hours. It thus can be administered by subcutaneous injection as well as continuous intravenous infusion. If the medication is administered subcutaneously, a limiting effect is pain and discomfort at the injection site. Treprostinil also can be given as a secondary agent by inhalation.